Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:00 am Sale | 2023-12-31 | 13G | Biohaven Ltd. BHVN | Point72 Asset Management, L.P. | 2,552,822 3.200% | -1,508,521 (-37.14%) | Filing History |
| 2024-02-14 06:45 am Sale | 2023-12-31 | 13G | Bionomics Limited BNOX | Point72 Asset Management, L.P. | 4,965,000 4.000% | -4,959,390 (-49.97%) | Filing History |
| 2024-02-14 06:45 am Sale | 2023-12-31 | 13G | Rapid7, Inc. RPD | Point72 Asset Management, L.P. | 1,877,611 3.100% | -1,214,659 (-39.28%) | Filing History |
| 2024-02-14 06:30 am Sale | 2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 3,997,545 4.500% | -87,999 (-2.15%) | Filing History |
| 2024-02-14 06:30 am Sale | 2023-12-31 | 13G | Chewy, Inc. CHWY | Point72 Asset Management, L.P. | 1,591,442 1.300% | -5,114,441 (-76.27%) | Filing History |
| 2024-02-14 06:29 am Sale | 2023-12-31 | 13G | Inari Medical, Inc. NARI | Point72 Asset Management, L.P. | 1,175,150 2.000% | -1,620,202 (-57.96%) | Filing History |
| 2024-02-14 06:17 am Sale | 2023-12-31 | 13G | Pulmonx Corporation LUNG | Point72 Asset Management, L.P. | 1,546,089 4.000% | -425,721 (-21.59%) | Filing History |
| 2024-02-14 06:16 am Sale | 2023-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Point72 Asset Management, L.P. | 468,821 0.200% | -7,646,069 (-94.22%) | Filing History |
| 2024-02-14 06:15 am Sale | 2023-12-31 | 13G | Fastly, Inc. FSLY | Point72 Asset Management, L.P. | 68,184 0.100% | -6,141,507 (-98.90%) | Filing History |
| 2024-02-14 06:11 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 209,971 0.200% | -4,323,785 (-95.37%) | Filing History |
| 2024-02-14 06:03 am Sale | 2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Point72 Asset Management, L.P. | 825,000 3.800% | -425,000 (-34.00%) | Filing History |
| 2024-02-14 06:01 am Sale | 2023-12-31 | 13G | CUTERA INC CUTRQ | Point72 Asset Management, L.P. | 214,800 1.100% | -929,607 (-81.23%) | Filing History |
| 2024-02-12 4:24 pm Purchase | 2024-02-02 | 13G | Annexon, Inc. ANNX | Point72 Asset Management, L.P. | 4,868,603 6.200% | 4,868,603 (New Position) | Filing History |
| 2024-02-09 4:08 pm Purchase | 2024-02-06 | 13G | Vaccinex, Inc. VCNX | Point72 Asset Management, L.P. | 413,818 9.900% | 413,818 (New Position) | Filing History |
| 2024-02-08 4:53 pm Purchase | 2024-02-07 | 13G | JOYY Inc. JOYY | Point72 Asset Management, L.P. | 45,329,900 5.100% | 45,329,900 (New Position) | Filing History |
| 2024-02-07 4:25 pm Purchase | 2024-02-06 | 13G | Alto Neuroscience, Inc. ANRO | Point72 Asset Management, L.P. | 1,692,778 6.300% | 1,692,778 (New Position) | Filing History |
| 2024-02-05 4:34 pm Purchase | 2024-02-02 | 13G | Sagimet Biosciences Inc. SGMT | Point72 Asset Management, L.P. | 1,612,639 5.300% | 1,612,639 (New Position) | Filing History |
| 2024-01-31 4:55 pm Purchase | 2024-01-30 | 13G | Iterum Therapeutics plc ITRM | Point72 Asset Management, L.P. | 850,001 6.300% | 850,001 (New Position) | Filing History |
| 2024-01-31 4:54 pm Purchase | 2024-01-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Point72 Asset Management, L.P. | 4,867,706 5.200% | 3,680,108 (+309.88%) | Filing History |
| 2024-01-29 4:40 pm Purchase | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Point72 Asset Management, L.P. | 388,676 8.800% | 388,676 (New Position) | Filing History |